首页> 外文期刊>Chimie Nouvelle >Designing Photoreactive Ruthenium~(II) Complexes for Biomedical Applications
【24h】

Designing Photoreactive Ruthenium~(II) Complexes for Biomedical Applications

机译:设计用于生物医学应用的光反应性钌〜(II)配合物

获取原文
获取原文并翻译 | 示例
           

摘要

The development of therapeutic agents represents one of the main research objectives in the fight against cancer. In this context, the "laboratoire de Chimie Organique et Photochimie" focuses its interest in the design of photoreactive Ruthenium~(II) complexes. The interesting photoreactivity is mainly due to thephotooxidizing properties of complexes bearing π-deficient ligands. It has been demonstrated that a photo-induced electron transfer (PET) is indeed possible between a DNA guanine moiety and a Ru" complex containing at least two π-acceptingligands. Thisprimary PET process can lead to the formation of a photoadduct, in which a covalent link is formed between the Ru~(II) complex and a DNA strand. This covalent bitiding allows the development of gene silencing strategies where two complementary oligonucleotides (ODNs) are irreversibly photocrosslinked.
机译:治疗剂的开发代表了抗癌的主要研究目标之一。在这种情况下,“化学实验室和光化学实验室”将其兴趣集中在光反应性钌(II)配合物的设计上。有趣的光反应性主要是由于带有π缺陷配体的配合物的光氧化性能。已经证明,在DNA鸟嘌呤部分和含有至少两个π-接受配体的Ru”络合物之间确实可能进行光致电子转移(PET)。该主要的PET过程可以导致光加合物的形成,其中Ru〜(II)配合物与DNA链之间形成共价键,这种共价键合可以发展基因沉默策略,其中两个互补寡核苷酸(ODN)不可逆地进行光交联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号